達拉非尼合併曲美替尼治療BRAF V600突變型兒童膠質瘤－《新英格蘭醫學雜誌》

正文內容

Original ArticleSep 21,2023FREETrial of Solanezumab in Preclinical Alzheimer’s DiseaseR. A. Sperling and Others Original ArticleSep 21,2023FREESemaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityM. N. Kosiborod and Others Original ArticleSep 21,2023FREEInhaled Fluticasone Furoate for Outpatient Treatment of Covid-19D. R. Boulware and Others Select the format you want to export the citation of this publication. Meziane Brizini, Sébastien Perreault, Julie Bennett, Hadeel Hassan, Advances in the management of pediatric low-grade glioma, Neurotherapeutics, 23,6, (e00952), (2026). https: //doi. org/10.1016/j. neurot. 2026. e00952Crossref Eric A. Grin, Spencer Frome, Joseph Turner, Jessica Clymer, Yosef Dastagirzada, David H. Harter, Sharon Gardner, Eveline Teresa Hidalgo, Devorah Segal, Incidence and predictors of hemorrhage in pediatric low-grade glioma, Journal of Neuro-Oncology, 178,3, (2026). https: //doi. org/10.1007/s11060-026-05699-wCrossref Eun Jung Koh, Digital Twins as the Implementation Layer of Precision Medicine in Pediatric Neurosurgery, Journal of Korean Neurosurgical Society, 69,4, (540-553), (2026). https: //doi. org/10.3340/jkns. 2026.0060Crossref Srividhya Senthil, Michail G. Matalliotakis, Stephen Hughes, Peter D. Arkwright, Mohan Shenoy, Robert Wynn, Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder, Frontiers in Immunology, 17, (2026). https: //doi. org/10.3389/fimmu. 2026.1850700Crossref Hillary S Andrews, Raja Agnihotram, Gideon Blumenthal, Julie Bullock, Grace Collins, Gary J Doherty, Anna F Farago, Yuko Ishii, Sreeneeranj Kasichayanula, Michael LeBlanc, Elena Levi-D’Ancona, Chunze Li, Karen McCullough, Phuong Khanh (PK) Morrow, Bernat Navarro, Punam Sandhu, Sujay Shah, Elad Sharon, Zhen Su, Carol Vallett, Yolanda Villalobos, Jeff D Allen, Mark D Stewart, Assessing contribution of effect in oncology combination therapies: lessons learned to inform and optimize future registrational trial designs, The Oncologist, 31,7, (2026). https: //doi. org/10.1093/oncolo/oyag222Crossref Eric Bouffet, David Neal Franz, Isabel Arrillaga-Romany, Rakesh Jalali, Approved Targeted Treatments for Pediatric Brain Tumors, American Society of Clinical Oncology Educational Book, 46,3, (2026). https: //doi. org/10.1200/EDBK-26-517598Crossref Uri Ilan, Alba Rubio-San-Simón, Natasha van Eijkelenburg, Cormac Owens, Aviva Kraus, Lucas Moreno, Fernando Carceller, Carole Lecinse, Leona Knox, Nicole Scobie, Birgit Geoerger, C. Michel Zwaan, Pamela Kearns, Francisco Bautista, Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium, European Journal of Cancer, 242, (116830), (2026). https: //doi. org/10.1016/j. ejca. 2026.116830Crossref Michael Pozin, Daniel Najafali, Benjamin Oakes, Simo Kraguljac, Jordan Whittles, Hana Seif, Muhammad Seif, Jason W. Yu, Fouad Hajjar, Roberto L. Flores, Joseph Lopez, A Primer for Pediatric Plastic Surgeons on Pediatric Head and Neck Malignancies, Annals of Plastic Surgery, 96,6, (541-551), (2026). https: //doi. org/10.1097/SAP. 0000000000004606Crossref Nicola Husain, Claire Booth, Joseph F. Standing, Charlotte I. S. Barker, Precision medicine in paediatrics: Progress and priorities, British Journal of Clinical Pharmacology, (2026). https: //doi. org/10.1002/bcp. 70573Crossref Trial of Solanezumab in Preclinical Alzheimer’s Disease Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19